HRP20050790A2 - New combinations and new use of selected pharmaceutically active compounds - Google Patents

New combinations and new use of selected pharmaceutically active compounds

Info

Publication number
HRP20050790A2
HRP20050790A2 HR20050790A HRP20050790A HRP20050790A2 HR P20050790 A2 HRP20050790 A2 HR P20050790A2 HR 20050790 A HR20050790 A HR 20050790A HR P20050790 A HRP20050790 A HR P20050790A HR P20050790 A2 HRP20050790 A2 HR P20050790A2
Authority
HR
Croatia
Prior art keywords
new
active compounds
pharmaceutically active
combinations
selected pharmaceutically
Prior art date
Application number
HR20050790A
Other languages
English (en)
Croatian (hr)
Inventor
Buhr Wilm
Jan Zimmermann Peter
Vittoria Chiesa M.
Palmer Andreas
Brehm Christof
Klein Thomas
Senn-Bilfinger Jörg
Simon Wolfgang-Alexander
Postius Stefan
Kromer Wolfgang
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HRP20050790A2 publication Critical patent/HRP20050790A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20050790A 2003-02-17 2005-09-09 New combinations and new use of selected pharmaceutically active compounds HRP20050790A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003530 2003-02-17
PCT/EP2004/050138 WO2004071391A2 (fr) 2003-02-17 2004-02-16 Nouvelles combinaisons et nouvelle utilisation de composes selectionnes actifs sur le plan pharmaceutique

Publications (1)

Publication Number Publication Date
HRP20050790A2 true HRP20050790A2 (en) 2006-12-31

Family

ID=32864938

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050790A HRP20050790A2 (en) 2003-02-17 2005-09-09 New combinations and new use of selected pharmaceutically active compounds

Country Status (18)

Country Link
US (1) US20060154954A1 (fr)
EP (1) EP1599175A2 (fr)
JP (1) JP2006517952A (fr)
KR (1) KR20050100671A (fr)
CN (1) CN1747731A (fr)
AR (1) AR044497A1 (fr)
AU (1) AU2004212337A1 (fr)
BR (1) BRPI0407541A (fr)
CA (1) CA2515676A1 (fr)
HR (1) HRP20050790A2 (fr)
IS (1) IS8014A (fr)
MX (1) MXPA05008490A (fr)
NO (1) NO20054160L (fr)
PL (1) PL377581A1 (fr)
RS (1) RS20050603A (fr)
TW (1) TW200418467A (fr)
WO (1) WO2004071391A2 (fr)
ZA (1) ZA200505451B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117315A1 (fr) * 2005-04-29 2006-11-09 Nycomed Gmbh Composes de promedicaments mutuels utilises comme agents anti-inflammatoires a activite gastro-intestinale protectrice
WO2006117316A1 (fr) * 2005-04-29 2006-11-09 Nycomed Gmbh Composes de promedicaments mutuels utilises comme agents anti-inflammatoires a activite gastro-intestinale protectrice
EP2080513A1 (fr) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tétrahydropyridoéthers pour le traitement de la DMA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) * 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery
EP1127059B1 (fr) * 1998-11-03 2008-02-20 Nycomed GmbH Imidazonaphtyridines
SI1173439T1 (en) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
MXPA02009550A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
BR0109483A (pt) * 2000-03-29 2003-06-10 Altana Pharma Ag Pró-drogas de derivados de imidazopiridina
AU783764B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Alkylated imidazopyridine derivatives
ATE356131T1 (de) * 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine
CA2426616A1 (fr) * 2000-10-25 2002-05-02 Altana Pharma Ag Imidazopyridines polysubstituees utilisees comme inhibiteurs des secretions gastriques
IL157461A0 (en) * 2001-03-08 2004-03-28 Astrazeneca Ab Astrazeneca Ab Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines

Also Published As

Publication number Publication date
RS20050603A (en) 2007-09-21
PL377581A1 (pl) 2006-02-06
MXPA05008490A (es) 2005-10-18
AU2004212337A1 (en) 2004-08-26
BRPI0407541A (pt) 2006-02-14
NO20054160D0 (no) 2005-09-07
ZA200505451B (en) 2006-08-30
KR20050100671A (ko) 2005-10-19
CN1747731A (zh) 2006-03-15
TW200418467A (en) 2004-10-01
US20060154954A1 (en) 2006-07-13
WO2004071391A2 (fr) 2004-08-26
NO20054160L (no) 2005-11-14
IS8014A (is) 2005-09-08
AR044497A1 (es) 2005-09-14
JP2006517952A (ja) 2006-08-03
EP1599175A2 (fr) 2005-11-30
WO2004071391A3 (fr) 2005-05-12
CA2515676A1 (fr) 2004-08-26

Similar Documents

Publication Publication Date Title
BRPI0411825B8 (pt) inibidores de p38 quinase a base de heterociclo de 5 elementos, seus processos de preparação e seus usos, bem como composição farmacêutica
BR0007447A (pt) 2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas substituìdas, composições farmacêuticas e métodos
WO2006032342A3 (fr) Medicament contenant des composes carbonyles et leur utilisation
WO2007044050A3 (fr) Composés tricycliques basés sur la 1h-imidazo[4,5-d]thiéno[3,2-b]pyridine et préparations pharmaceutiques les incluant
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
CY1106816T1 (el) 1,5-δισυποκαταστημενες ενωσεις 3,4-διυδρο-1h-πυριμιδο [4,5-d] πυριμιδιν-2-ονης και η χρησιμοποιηση αυτων δια τη θεραπευτικη αγωγη ασθενειων εις τις οποιες μεσολαβει η csbp/p38 κιναση
WO2004006858A3 (fr) Composes, compositions et methodes d'utilisation de ces derniers
HK1096392A1 (en) Substituted heterocycles
UA85559C2 (en) Aminobenzophenone compounds
SE0301653D0 (sv) Novel compounds
ECSP055844A (es) Nuevos compuestos triciclicos
CY1108808T1 (el) Ενωσεις μοτιλιδης
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
ATE482211T1 (de) Imidazoä1,2-aüpyridin-anxiolytika
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
ECSP034872A (es) Nuevos heterociclos 3
EP1436279B8 (fr) Composes chimiques
ATE272642T1 (de) Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
SE0004099D0 (sv) Novel compounds
SE0100297D0 (sv) New compounds
DE50004023D1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one
SE0004098D0 (sv) Novel compounds
SE0100296D0 (sv) New compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080211

Year of fee payment: 5

OBST Application withdrawn